CORRECTION
Published on 29 Jan 2020
Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis
![Corrigendum: 2-Pyrrolidinone and Succinimide as Clinical Screening Biomarkers for GABA-Transaminase Deficiency: Anti-seizure Medications Impact Accurate Diagnosis](https://www.frontiersin.org/files/myhome article library/510574/510574_Thumb_400.jpg)
doi 10.3389/fnins.2019.01344
- 2,115 views
- 2 citations